{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T22:08:51Z","timestamp":1788386931499,"version":"build-2803163510"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.canlet.2019.05.026","type":"journal-article","created":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T12:37:38Z","timestamp":1558615058000},"page":"268-276","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["The anthelmintic flubendazole blocks human melanoma growth and metastasis and suppresses programmed cell death protein-1 and myeloid-derived suppressor cell accumulation"],"prefix":"10.1016","volume":"459","author":[{"given":"Yue","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grishma","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Elahy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3446-0323","authenticated-orcid":false,"given":"Levon M.","family":"Khachigian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2019.05.026_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5826\/dpc.0702a01","article-title":"Epidemiological trends in skin cancer","volume":"7","author":"Apalla","year":"2017","journal-title":"Dermatol. Pract. Concept."},{"key":"10.1016\/j.canlet.2019.05.026_bib2","series-title":"Treatment of Melanoma Skin Cancer","author":"American_Cancer_Society","year":"2018"},{"key":"10.1016\/j.canlet.2019.05.026_bib3","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrclinonc.2017.43","article-title":"Targeted agents and immunotherapies: optimizing outcomes in melanoma","volume":"14","author":"Luke","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2019.05.026_bib4","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/107327481402100308","article-title":"PD-1 pathway inhibitors: changing the landscape of cancer immunotherapy","volume":"21","author":"Dolan","year":"2014","journal-title":"Cancer Control"},{"key":"10.1016\/j.canlet.2019.05.026_bib5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nri.2017.108","article-title":"The diverse functions of the PD1 inhibitory pathway","volume":"18","author":"Sharpe","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.canlet.2019.05.026_bib6","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1408747","article-title":"Blockade of Tumor-Expressed PD-1 promotes lung cancer growth","volume":"7","author":"Du","year":"2018","journal-title":"OncoImmunology"},{"key":"10.1016\/j.canlet.2019.05.026_bib7","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.cell.2015.08.052","article-title":"Melanoma cell-intrinsic PD-1 receptor functions promote tumor growth","volume":"162","author":"Kleffel","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2019.05.026_bib8","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1172\/JCI40040","article-title":"PD-L1 has distinct functions in hematopoietic and nonhematopoietic cells in regulating T cell responses during chronic infection in mice","volume":"120","author":"Mueller","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2019.05.026_bib9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40425-018-0316-z","article-title":"Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations","volume":"6","author":"Gong","year":"2018","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.canlet.2019.05.026_bib10","doi-asserted-by":"crossref","first-page":"311","DOI":"10.18632\/oncoscience.328","article-title":"Genetic biomarkers for PD-1\/PD-L1 blockade therapy","volume":"3","author":"Kataoka","year":"2016","journal-title":"Oncoscience"},{"key":"10.1016\/j.canlet.2019.05.026_bib11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1504030","article-title":"Combined nivolumab and ipilimumab or monotherapy in untreated melanoma","volume":"373","author":"Larkin","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2019.05.026_bib12","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41416-018-0131-9","article-title":"Efficacy and safety of pembrolizumab in recurrent\/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012","volume":"119","author":"Mehra","year":"2018","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2019.05.026_bib13","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1200\/JCO.2016.70.1524","article-title":"Pembrolizumab for platinum- and cetuximab-refractory head and neck cancer: results from a single-arm, phase II study","volume":"35","author":"Bauml","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2019.05.026_bib14","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1056\/NEJMoa1602252","article-title":"Nivolumab for recurrent squamous-cell carcinoma of the head and neck","volume":"375","author":"Ferris","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2019.05.026_bib15","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1097\/COC.0000000000000429","article-title":"Pembrolizumab for the treatment of advanced salivary gland carcinoma: findings of the phase 1b KEYNOTE-028 study","volume":"41","author":"Cohen","year":"2018","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2019.05.026_bib16","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1080\/1061186X.2018.1440400","article-title":"Development of small-molecule immune checkpoint inhibitors of PD-1\/PD-L1 as a new therapeutic strategy for tumour immunotherapy","volume":"27","author":"Li","year":"2019","journal-title":"J. Drug Target."},{"key":"10.1016\/j.canlet.2019.05.026_bib17","series-title":"The CB17\/Icr-Prkdcscid\/IcrIcoCrl Mouse","author":"Charles_River","year":"2009"},{"key":"10.1016\/j.canlet.2019.05.026_bib18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/bjc.2017.434","article-title":"Mechanisms of resistance to immune checkpoint inhibitors","volume":"118","author":"Jenkins","year":"2018","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2019.05.026_bib19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3233\/BD-2010-0307","article-title":"Triple negative breast cancer cell lines: one tool in the search for better treatment of triple negative breast cancer","volume":"32","author":"Chavez","year":"2010","journal-title":"Breast Dis."},{"key":"10.1016\/j.canlet.2019.05.026_bib20","doi-asserted-by":"crossref","first-page":"15002","DOI":"10.1038\/npjbcancer.2015.2","article-title":"Continued use of MDA-MB-435, a melanoma cell line, as a model for human breast cancer, even in year, 2014","volume":"1","author":"Prasad","year":"2015","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.canlet.2019.05.026_bib21","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1023\/A:1006719800907","article-title":"Characterization of spontaneous metastasis in an aggressive breast carcinoma model using flow cytometry","volume":"17","author":"Schmidt","year":"1999","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.canlet.2019.05.026_bib22","series-title":"Magnetic Resonance in Experimental and Clinical Oncology","author":"Evelhoch","year":"1989"},{"key":"10.1016\/j.canlet.2019.05.026_bib23","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000246103","article-title":"Serum S100-a marker for disease monitoring in metastatic melanoma","volume":"194","author":"Henze","year":"1997","journal-title":"Dermatology"},{"key":"10.1016\/j.canlet.2019.05.026_bib24","doi-asserted-by":"crossref","first-page":"69139","DOI":"10.18632\/oncotarget.19932","article-title":"The roles of signal transducer and activator of transcription factor 3 in tumor angiogenesis","volume":"8","author":"Gao","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2019.05.026_bib25","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1172\/JCI41936","article-title":"Myeloid-derived suppressor cells are implicated in regulating permissiveness for tumor metastasis during mouse gestation","volume":"121","author":"Mauti","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2019.05.026_bib26","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.4049\/jimmunol.0802740","article-title":"Myeloid-derived suppressor cells: linking inflammation and cancer","volume":"182","author":"Ostrand-Rosenberg","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2019.05.026_bib27","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/mc.22767","article-title":"Inhibition of JAK2\/STAT3 reduces tumor-induced angiogenesis and myeloid-derived suppressor cells in head and neck cancer","volume":"57","author":"Liu","year":"2018","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.canlet.2019.05.026_bib28","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1002\/ijc.31585","article-title":"Flubendazole elicits anti-metastatic effects in triple-negative breast cancer via STAT3 inhibition","volume":"143","author":"Oh","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2019.05.026_bib29","doi-asserted-by":"crossref","first-page":"6326","DOI":"10.18632\/oncotarget.3436","article-title":"Flubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells","volume":"6","author":"Hou","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2019.05.026_bib30","doi-asserted-by":"crossref","first-page":"4824","DOI":"10.1182\/blood-2009-09-243055","article-title":"The antihelmintic flubendazole inhibits microtubule function through a mechanism distinct from Vinca alkaloids and displays preclinical activity in leukemia and myeloma","volume":"115","author":"Spagnuolo","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2019.05.026_bib31","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41420-017-0017-2","article-title":"Flubendazole inhibits glioma proliferation by G2\/M cell cycle arrest and pro-apoptosis","volume":"4","author":"Zhou","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2019.05.026_bib32","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3389\/fimmu.2018.00398","article-title":"Targeting myeloid-derived suppressor cells to bypass tumor-induced immunosuppression","volume":"9","author":"Fleming","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2019.05.026_bib33","series-title":"A Review of Flubendazole and its Potential as a Macrofilariacide","author":"Mackenzie","year":"2012"},{"key":"10.1016\/j.canlet.2019.05.026_bib34","series-title":"FLUBENDAZOLE_EMEA\/CVMP\/33128\/2006-FINAL","author":"European_Medicines_Agency","year":"2006"},{"key":"10.1016\/j.canlet.2019.05.026_bib35","doi-asserted-by":"crossref","first-page":"627","DOI":"10.4269\/ajtmh.1984.33.627","article-title":"Treatment of neurocysticercosis with flubendazole","volume":"33","author":"Tellez-Giron","year":"1984","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.canlet.2019.05.026_bib36","first-page":"314","article-title":"Treatment of human alveolar echinococcosis with flubendazole. Clinical, morphological and immunological study","volume":"8","author":"Lassegue","year":"1984","journal-title":"Gastroenterol. Clin. Biol."},{"key":"10.1016\/j.canlet.2019.05.026_bib37","doi-asserted-by":"crossref","first-page":"8202","DOI":"10.1038\/srep08202","article-title":"Identification of flubendazole as potential anti-neuroblastoma compound in a large cell line screen","volume":"5","author":"Michaelis","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2019.05.026_bib38","doi-asserted-by":"crossref","first-page":"4876","DOI":"10.4049\/jimmunol.1302750","article-title":"STAT3, STAT4, NFATc1, and CTCF regulate PD-1 through multiple novel regulatory regions in murine T cells","volume":"192","author":"Austin","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2019.05.026_bib39","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2119\/molmed.2017.00011","article-title":"Repurposing mebendazole as a replacement for vincristine for the treatment of brain tumors","volume":"23","author":"De Witt","year":"2017","journal-title":"Molecular medicine (Cambridge, MA)"},{"key":"10.1016\/j.canlet.2019.05.026_bib40","first-page":"3659","article-title":"Complexation of albendazole with hydroxypropyl-beta-cyclodextrin significantly improves its pharmacokinetic profile, cell cytotoxicity and antitumor efficacy in nude mice","volume":"32","author":"Ehteda","year":"2012","journal-title":"Anticancer Res."},{"key":"10.1016\/j.canlet.2019.05.026_bib41","first-page":"2218","article-title":"Oxibendazole inhibits prostate cancer cell growth","volume":"15","author":"Chen","year":"2018","journal-title":"Oncol Lett"},{"key":"10.1016\/j.canlet.2019.05.026_bib42","first-page":"962","article-title":"Thiabendazole, a well-known antifungal drug, exhibits anti-metastatic melanoma B16F10 activity via inhibiting VEGF expression and inducing apoptosis","volume":"68","author":"Zhang","year":"2013","journal-title":"Pharmazie"},{"key":"10.1016\/j.canlet.2019.05.026_bib43","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1080\/13543776.2018.1512706","article-title":"A patent review on PD-1\/PD-L1 antagonists: small molecules, peptides, and macrocycles (2015-2018)","volume":"28","author":"Shaabani","year":"2018","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.canlet.2019.05.026_bib44","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev.bi.64.070195.003201","article-title":"Transcriptional responses to polypeptide ligands: the JAK-STAT pathway","volume":"64","author":"Schindler","year":"1995","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.canlet.2019.05.026_bib45","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.nbd.2010.09.018","article-title":"STAT3 inhibitors attenuate interferon-gamma-induced neurotoxicity and inflammatory molecule production by human astrocytes","volume":"41","author":"Hashioka","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.canlet.2019.05.026_bib46","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1600-065X.2010.00923.x","article-title":"The PD-1 pathway in tolerance and autoimmunity","volume":"236","author":"Francisco","year":"2010","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.canlet.2019.05.026_bib47","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1749-6632.2010.05919.x","article-title":"The role of the PD-1 pathway in autoimmunity and peripheral tolerance","volume":"1217","author":"Fife","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.canlet.2019.05.026_bib48","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1158\/2326-6066.CIR-17-0708","article-title":"IL21 therapy combined with PD-1 and tim-3 blockade provides enhanced NK cell antitumor activity against MHC class I-deficient tumors","volume":"6","author":"Seo","year":"2018","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.canlet.2019.05.026_bib49","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1172\/JCI99317","article-title":"Contribution of NK cells to immunotherapy mediated by PD-1\/PD-L1 blockade","volume":"128","author":"Hsu","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2019.05.026_bib50","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature22396","article-title":"PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity","volume":"545","author":"Gordon","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2019.05.026_bib51","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/eji.201041353","article-title":"The STATus of PD-L1 (B7-H1) on tolerogenic APCs","volume":"41","author":"Sumpter","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.canlet.2019.05.026_bib52","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1182\/blood-2010-02-271874","article-title":"The PD-1\/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody","volume":"116","author":"Benson","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2019.05.026_bib53","doi-asserted-by":"crossref","first-page":"6143","DOI":"10.1038\/onc.2017.209","article-title":"Increased expression of programmed cell death protein 1 on NK cells inhibits NK-cell-mediated anti-tumor function and indicates poor prognosis in digestive cancers","volume":"36","author":"Liu","year":"2017","journal-title":"Oncogene"},{"issue":"Suppl 6","key":"10.1016\/j.canlet.2019.05.026_bib54","first-page":"S3","article-title":"Taxol (paclitaxel): mechanisms of action","volume":"5","author":"Horwitz","year":"1994","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canlet.2019.05.026_bib55","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00262-008-0586-2","article-title":"Paclitaxel reduces regulatory T cell numbers and inhibitory function and enhances the anti-tumor effects of the TLR9 agonist PF-3512676 in the mouse","volume":"58","author":"Vicari","year":"2009","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.canlet.2019.05.026_bib56","first-page":"3689","article-title":"Cyclophosphamide, doxorubicin, and paclitaxel enhance the antitumor immune response of granulocyte\/macrophage-colony stimulating factor-secreting whole-cell vaccines in HER-2\/neu tolerized mice","volume":"61","author":"Machiels","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2019.05.026_bib57","doi-asserted-by":"crossref","first-page":"5891","DOI":"10.1158\/0008-5472.CAN-17-3480","article-title":"Paclitaxel reduces tumor growth by reprogramming tumor-associated macrophages to an M1 profile in a TLR4-dependent manner","volume":"78","author":"Wanderley","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2019.05.026_bib58","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/CJI.0b013e318176fae4","article-title":"Low-dose chemotherapeutic agents regulate small Rho GTPase activity in dendritic cells","volume":"31","author":"Shurin","year":"2008","journal-title":"J. Immunother."},{"key":"10.1016\/j.canlet.2019.05.026_bib59","doi-asserted-by":"crossref","first-page":"137","DOI":"10.4049\/jimmunol.0900734","article-title":"Chemotherapeutic agents in noncytotoxic concentrations increase antigen presentation by dendritic cells via an IL-12-dependent mechanism","volume":"183","author":"Shurin","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2019.05.026_bib60","doi-asserted-by":"crossref","first-page":"5455","DOI":"10.1158\/1078-0432.CCR-07-0517","article-title":"Low-dose paclitaxel prior to intratumoral dendritic cell vaccine modulates intratumoral cytokine network and lung cancer growth","volume":"13","author":"Zhong","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2019.05.026_bib61","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.tiv.2017.10.025","article-title":"Flubendazole induces mitotic catastrophe and apoptosis in melanoma cells","volume":"46","author":"Canova","year":"2018","journal-title":"Toxicol. In Vitro"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383519303210?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383519303210?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T14:01:36Z","timestamp":1663509696000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383519303210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":61,"alternative-id":["S0304383519303210"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2019.05.026","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The anthelmintic flubendazole blocks human melanoma growth and metastasis and suppresses programmed cell death protein-1 and myeloid-derived suppressor cell accumulation","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2019.05.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}